Elevated plasma levels of transforming growth factor β1 in patients with muscular dystrophy

被引:48
作者
Ishitobi, M
Haginoya, K [1 ]
Zhao, YJ
Ohnuma, A
Minato, J
Yanagisawa, T
Tanabu, M
Kikuchi, M
Iinuma, K
机构
[1] Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 9808574, Japan
[2] Takutou Rehabil Ctr Disabled Children, Dept Pediat, Sendai, Miyagi, Japan
[3] China Med Univ, Clin Coll 2, Dept Pediat, Shenyang, Peoples R China
[4] Fukushima Hosp Handicapped Children, Dept Orthoped & Pediat, Iwaki, Fukushima, Japan
[5] Hachinohe Municipal Hosp, Dept Pediat, Hachinohe, Japan
[6] Hitachi Gen Hosp, Dept Pediat, Hitachi, Ibaraki, Japan
关键词
ELISA; fibrosis; muscular dystrophy; transforming growth factor;
D O I
10.1097/00001756-200012180-00026
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The progression of muscular weakness of patients suffering from muscular dystrophies directly correlates with the progressive loss of myofibers, accompanied by fibrosis. Since transforming growth factor beta1 (TGF-beta1) promotes tissue fibrosis, we measured the plasma TGF-beta1 level in patients with various muscular dystrophies in order to determine whether the level is elevated in patients with muscular dystrophy and if the level reflects the severity of tissue fibrosis. The plasma TGF-beta1 level was significantly elevated in patients with Duchenne muscular dystrophy and congenital muscular dystrophy (CMD), but not in those with Becker muscular dystrophy. Growth factors related to muscle fiber regeneration and fibrosis might be a key factor in the progression of muscular dystrophy and could be a target for therapeutic studies. NeuroReport 11:4033-4035 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:4033 / 4035
页数:3
相关论文
共 19 条
[1]   Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies [J].
Bernasconi, P ;
Di Blasi, C ;
Mora, M ;
Morandi, L ;
Galbiati, S ;
Confalonieri, P ;
Cornelio, F ;
Mantegazza, R .
NEUROMUSCULAR DISORDERS, 1999, 9 (01) :28-33
[2]   EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN DYSTROPHIC PATIENT MUSCLES CORRELATES WITH FIBROSIS - PATHOGENETIC ROLE OF A FIBROGENIC CYTOKINE [J].
BERNASCONI, P ;
TORCHIANA, E ;
CONFALONIERI, P ;
BRUGNONI, R ;
BARRESI, R ;
MORA, M ;
CORNELIO, F ;
MORANDI, L ;
MANTEGAZZA, R .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) :1137-1144
[3]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[5]   Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate [J].
Confalonieri, P ;
Bernasconi, P ;
Cornelio, F ;
Mantegazza, R .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05) :479-484
[6]   ELEVATED BASIC FIBROBLAST GROWTH-FACTOR IN THE SERUM OF PATIENTS WITH DUCHENNE MUSCULAR-DYSTROPHY [J].
DAMORE, PA ;
BROWN, RH ;
KU, PT ;
HOFFMAN, EP ;
WATANABE, H ;
ARAHATA, K ;
ISHIHARA, T ;
FOLKMAN, J .
ANNALS OF NEUROLOGY, 1994, 35 (03) :362-365
[7]  
DUBOWITZ V, 1985, MUSCLE BIOPSY PRACTI, P289
[8]   FIBROBLAST-CULTURES IN DUCHENNE MUSCULAR-DYSTROPHY - ALTERATIONS IN SYNTHESIS AND SECRETION OF COLLAGEN AND NON-COLLAGEN PROTEINS [J].
IONASESCU, V ;
LARABRAUD, C ;
ZELLWEGER, H ;
IONASESCU, R ;
BURMEISTER, L .
ACTA NEUROLOGICA SCANDINAVICA, 1977, 55 (05) :407-417
[9]   Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney [J].
Isaka, Y ;
Brees, DK ;
Ikegaya, K ;
Kaneda, Y ;
Imai, E ;
Noble, NA ;
Border, WA .
NATURE MEDICINE, 1996, 2 (04) :418-423
[10]   Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (occidental) merosin-positive form [J].
Kobayashi, O ;
Hayashi, Y ;
Arahata, K ;
Ozawa, E ;
Nonaka, I .
NEUROLOGY, 1996, 46 (03) :815-818